The Italian pharmaceutical company’s turnover has exceeded all expectations: 654 million Euro, with an increase of 11.2% compared to 2006. An excellent performance by Italy and the foreign affiliates in Germany, Austria, Eastern Europe, Brazil and the UK. The Group has an even stronger presence on the International market after two affiliates were opened in the Netherlands and Turkey. Investments in R&D are also on the up, and have increased to 13.8% of the total turnover. More than 200 patents were taken out in 2007.
